search
Back to results

Trial Of Normal Saline Versus Ringer's Lactate In Paediatric Trauma Patients

Primary Purpose

Trauma

Status
Completed
Phase
Phase 4
Locations
Canada
Study Type
Interventional
Intervention
Normal Saline
Ringer's Lactate
Sponsored by
Lawson Health Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Trauma focused on measuring Trauma, Pediatric, Intravenous Fluid, Normal Saline, Ringer's Lactate

Eligibility Criteria

1 Year - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Pediatric trauma patients with Injury Severity Score greater than 12
  • Age 1-17 years
  • Trauma within 8 hours

Exclusion Criteria:

  • Injury Severity Score less than 12
  • Pre-existing renal disease
  • On medication that affects serum sodium (i.e diuretic therapy)
  • Blood transfusion within first 24 hours
  • Operation within first 24 hours
  • Oral intake of fluid or solids in first 24 hours

Sites / Locations

  • Children's Hospital, London Health Sciences Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Normal Saline

Ringer's Lactate

Arm Description

Patients will receive intravenous normal saline for all resuscitation and maintenance fluid for a period of 24 hours commencing on presentation to hospital.

Patients will receive intravenous Ringer's Lactate for all resuscitation and maintenance fluid for a period of 24 hours commencing on presentation to hospital.

Outcomes

Primary Outcome Measures

The difference in serum sodium change over 24 hours between patients receiving NS versus RL

Secondary Outcome Measures

The difference in serum pH
The difference serum chloride
The differences in serum bicarbonate
The differences in serum inflammatory biomarker change: Erythrocyte Sedimentation Rate (ESR)
The differences in serum inflammatory biomarker change: C-Reactive Protein
The differences in serum inflammatory biomarker change: InterLeukin-6
The differences in serum inflammatory biomarker change InterLeukin-8
The differences in serum inflammatory biomarker change: G-CSF
The differences in serum inflammatory biomarker change: MCP-1

Full Information

First Posted
September 19, 2012
Last Updated
November 2, 2018
Sponsor
Lawson Health Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT01692769
Brief Title
Trial Of Normal Saline Versus Ringer's Lactate In Paediatric Trauma Patients
Official Title
Randomized Controlled Trial of Intravenous Fluid In Severely Injured Paediatric Trauma Patients: Comparison of Normal Saline Versus Ringer's Lactate
Study Type
Interventional

2. Study Status

Record Verification Date
November 2018
Overall Recruitment Status
Completed
Study Start Date
May 2013 (Actual)
Primary Completion Date
August 2014 (Actual)
Study Completion Date
December 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Lawson Health Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: Trauma is a major cause of death in children and teenagers. When young patients have suffered major traumatic injuries, they require intravenous (iv) fluids to keep their blood vessels full and ensure blood flow to vital organs. Current fluid guidelines by International Trauma Committees recommend either Normal Saline (NS) or Ringer's Lactate (RL) as the fluid of choice for these patients. Although these solutions share some similarities in their composition, there are also some significant differences in sodium, chloride and lactate concentrations. Despite these differences in fluid composition, there has never been a study comparing these two fluids in paediatric trauma patients to determine which is optimal. In this study, the investigators aim to determine the optimal fluid choice for trauma resuscitation of young patients. Hypothesis: The investigators hypothesize that severely injured paediatric trauma patients resuscitated with NS will have optimal blood sodium levels compared to patients resuscitated with RL. Methods: The investigators will study 50 paediatric trauma patients that will be randomized so that half will randomly receive NS and half will receive RL as their only iv fluid for 24 hours. After 24 hours, the investigators will compare in blood the sodium level, the amount of acid, and the concentrations of inflammation molecules in relation to those whom received NS versus RL. Expected Results and Significance: Maintaining optimal levels of these biochemical markers is imperative in reducing morbidity and mortality in severely injured paediatric patients. If significant differences are present, the investigators will be able to determine which fluid is preferred and expect these data to complement current trauma resuscitation guidelines.
Detailed Description
Background: Trauma is the major killer of children and adolescents. The care of paediatric trauma patients is guided by the Advanced Trauma Life Support (ATLS) guidelines. Fluid resuscitation is a critical aspect of trauma resuscitation to avoid hypoperfusion and metabolic acidosis, and to maintain adequate oxygen delivery to tissues. ATLS recommends the use of either intravenous Normal Saline (NS) or Ringer's Lactate (RL) in trauma fluid resuscitation. There are currently no recommendations or any studies to suggest which of these two fluids are more appropriate for pediatric trauma patients and their ionic compositions do differ. As such, both solutions have potential benefits and potential complications. There are three primary issues that relate to choice of solution. Sodium concentration and risk of iatrogenic hyponatremia: NS has higher sodium content relative to RL (154 vs. 130 mmol/L, respectively; normal blood levels are 135-145 mmol/L). Maintenance of a normal or slightly elevated sodium level in paediatric trauma patients is often imperative, given that the vast majority of these patients have significant traumatic brain injury. Hyponatremia can worsen cerebral edema and increase intracranial pressure. In a previous study conducted by us at Children's Hospital, LHSC we reported that paediatric trauma patients in our centre received NS. Despite NS used as the resuscitation fluid, pediatric trauma patients all showed a trend towards low-normal levels of sodium in their blood. Given the lower content of sodium in RL, we question whether NS is superior for maintenance of blood sodium. Chloride concentration and risk of iatrogenic hyperchloremic metabolic acidosis: NS contains significantly more chloride than RL to maintain electro-neutrality (154 vs. 109 mmol, respectively; normal blood levels are 98-108 mmol/L). In contrast, the RL solution replaces 28 mmol/L of chloride with equimolar lactate. As the elevated chloride content in NS is postulated to instigate the undesired consequences of driving blood bicarbonate lower and producing a hyperchloremic metabolic acidosis,6, 7 we question whether NS is inferior to RL for maintenance of blood pH. Exacerbation of trauma-induced inflammation: Trauma results in a systemic inflammatory response (Fraser Lab, unpublished results). Exacerbation of the inflammatory state with non-optimal resuscitation practices might worsen overall outcome. Published data on non-trauma patients suggests that NS administration is pro-inflammatory relative to RL,9 but this possibility has not been studied in paediatric patients, or in any trauma patients. The inflammatory cascade can be assessed in blood by measuring the levels of global inflammatory markers [erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)] and specific pro-inflammatory mediators elevated by multisystem trauma [interleukin-6 (IL-6), interleukin-8 (IL-8), granulocyte colony stimulating factor (G-CSF) and monocyte chemotactic protein-1 (MCP-1)]. Given the higher inflammatory potential that has been associated with NS, we question whether NS is inferior to RL for minimizing inflammatory cascades. Hypothesis: We hypothesize that severely injured paediatric trauma patients resuscitated with NS will have optimal blood sodium levels compared to patients resuscitated with RL, but at the expense of hyperchloremic metabolic acidosis and exaggerated inflammation. Methodology: This study will be a prospective, single-blinded, RCT of severely injured paediatric trauma patients admitted to the Children's Hospital, London Health Sciences Centre. While the clinical staff treating the patient will be aware of treatment group, the patient, as well as the laboratory technicians determining the serum changes will be blinded to the fluid administered. Randomization: Patients will be immediately randomized to either receive NS or RL as their resuscitation and maintenance fluid for the first 24 hours. Randomization, via selection of sealed envelope based on a computer-generated list, will be done by the trauma resuscitation room intravenous access nurse without delay on arrival. Intravenous access and solution administration occurs as a priority within minutes of arrival to the trauma room. Clinical Data and Blood Analyses: All patients included in this study will be entered into the LHSC Trauma Database, comprised of over 400 data elements, by a single, trained Trauma Data Analyst. The database regularly undergoes quality monitoring to ensure the data is complete and is of highest quality. Descriptive analyses and epidemiologic profiles on demographic, clinical and injury data will be undertaken, as we have published previously. A baseline trauma blood panel will be drawn upon presentation to our resuscitation room (Time "0"), and then repeated at 24 hours. Blood measurements for analyses will include serum sodium, chloride, bicarbonate, base excess, osmolality, blood gas, ESR and CRP. An extra blood vial will be taken and stored for batch analyses of pro-inflammatory cytokines by multiplex assay (IL- 6, IL-8, G-CSF and MCP-1). Other interventions will be carried out as per standard of care at the discretion of the Trauma most responsible physician. Any medications or any additional fluids the patients receive will be recorded. The total amount of intravenous fluid received in the first 24 hours will be measured for all patients. Data Analysis: Descriptive analyses and epidemiologic profiles on demographic, clinical and injury data will be undertaken, as we have published previously. Treatment groups will be compared using Mann Whitney U test for the outcome measures at 24 hours, as they are continuous. This will include the primary outcome variable (serum sodium) and the secondary outcome variables (serum chloride, bicarbonate, pH and inflammatory markers: ESR, C-RP, IL-6, Il-8, G-CSF, MCP-1).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Trauma
Keywords
Trauma, Pediatric, Intravenous Fluid, Normal Saline, Ringer's Lactate

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Normal Saline
Arm Type
Active Comparator
Arm Description
Patients will receive intravenous normal saline for all resuscitation and maintenance fluid for a period of 24 hours commencing on presentation to hospital.
Arm Title
Ringer's Lactate
Arm Type
Active Comparator
Arm Description
Patients will receive intravenous Ringer's Lactate for all resuscitation and maintenance fluid for a period of 24 hours commencing on presentation to hospital.
Intervention Type
Drug
Intervention Name(s)
Normal Saline
Other Intervention Name(s)
0.9% Normal Saline
Intervention Description
Patients randomized to Normal Saline arm, will receive intravenous normal saline for all resuscitation and maintenance fluid for a period of 24 hours commencing on presentation to hospital.
Intervention Type
Drug
Intervention Name(s)
Ringer's Lactate
Other Intervention Name(s)
Lactated Ringers
Intervention Description
Patients randomized to Ringer's Lactate arm, will receive intravenous Ringer's Lactate for all resuscitation and maintenance fluid for a period of 24 hours commencing on presentation to hospital.
Primary Outcome Measure Information:
Title
The difference in serum sodium change over 24 hours between patients receiving NS versus RL
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
The difference in serum pH
Time Frame
24 hours
Title
The difference serum chloride
Time Frame
24 hours
Title
The differences in serum bicarbonate
Time Frame
24 hours
Title
The differences in serum inflammatory biomarker change: Erythrocyte Sedimentation Rate (ESR)
Time Frame
24 hours
Title
The differences in serum inflammatory biomarker change: C-Reactive Protein
Time Frame
24 hours
Title
The differences in serum inflammatory biomarker change: InterLeukin-6
Time Frame
24 hours
Title
The differences in serum inflammatory biomarker change InterLeukin-8
Time Frame
24 hours
Title
The differences in serum inflammatory biomarker change: G-CSF
Time Frame
24 hours
Title
The differences in serum inflammatory biomarker change: MCP-1
Time Frame
24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pediatric trauma patients with Injury Severity Score greater than 12 Age 1-17 years Trauma within 8 hours Exclusion Criteria: Injury Severity Score less than 12 Pre-existing renal disease On medication that affects serum sodium (i.e diuretic therapy) Blood transfusion within first 24 hours Operation within first 24 hours Oral intake of fluid or solids in first 24 hours
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gurinder S Sangha, MD
Organizational Affiliation
London Health Sciences Centre, University of Western Ontario
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Douglas D Fraser, MD, PhD
Organizational Affiliation
London Health Sciences Centre, University of Western Ontario
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Hospital, London Health Sciences Centre
City
London
State/Province
Ontario
ZIP/Postal Code
N6A5W9
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Trial Of Normal Saline Versus Ringer's Lactate In Paediatric Trauma Patients

We'll reach out to this number within 24 hrs